1. Managing OPV supplies in India
Dr. Pradeep Haldar
Deputy Commissioner (Immunization)
Ministry of Health & Family Welfare
Government of India

2. IEAG Recommendation for SIAs in 2012
NID
tOPV
NID
tOPV
SNID (bOPV)
Endemic & risk states
SNID (bOPV)
Endemic & risk states
SNID (bOPV)
Endemic & risk states
SNID (bOPV)
Endemic & risk states
Jan
Feb
Mar
Apr
May
Jun 2

3. OPV procurement - Nov 2010 to Feb 2012
Total : million doses
Domestic procurement necessitated in order to meet shortfall due to inability by RITES to procure required quantity of vaccine

4. Procurement status : 2011 vs 2012
tOPV for NIDs
Procurement status : vs 2012
Jan to Mar 2011
Jan to Apr 2012
Total : 471 million
Total : 450 million

5. tOPV procurement – NIDs 2012
Requirement of tOPV for Jan/Feb 2012 NIDs: 450 mn doses
Indent for 450 mn doses placed through RITES in Jan 2011
RITES secured only million doses as shown below:
Thus, a shortfall of mn doses for the 2 NIDs
Company
Qty offered
Remarks 1
Haffkine
109.37
83.58 mn for Jan 12 and mn for Feb 12 2
Panacea
184.70
Unable to supply as temporarily withdrawn WHO prequalification status. 3
Sanofi
127.62
Technically disqualified due to short shelf life.

6. tOPV Vaccine for NID contd…
Domestic procurement initiated to meet the shortfall of million doses
Still a shortfall of for 2 NIDs taking into account the availability through RITES and Domestic procurement
2nd tender floated to meet shortfall – vaccine available only in April 2012
tOPV availability (in million doses)
S No
Company
Qty offered
Remarks 1
Bharat
125
50 for Jan & 75 for Feb 2
Haffkine
109
19 by Feb & 90 by Mar 3
Panacea
13.4
Not accepted on tech ground
Total available
234

7. tOPV Vaccine for NID 2012 - Summary
Vaccine availability:
Shortfall of 47% for Jan & 50% for Feb NID.
Available supplies for both NIDs combined to conduct 1st NID on 19 February 2012
Since part of vaccine requirement for 2nd NID available only by 5 April 2012, 2nd NID planned on 15 April 2012
S.No.
Company
Quantity
Remarks
January 2012 Round 1
Haffkine
69.65
RITES 2
Bharat Biotech 50
Domestic
Total Vaccine available for Jan
119.65
February 2012 Round
39.7 75
Total Vaccine available for Feb
114.7

8. SIA calendar – 2012 revised as below
NID
tOPV
NID
tOPV
SNID (bOPV)
Endemic & risk states
SNID (bOPV)
Endemic & risk states
SNID (bOPV)
Endemic & risk states
SNID (bOPV)
Endemic & risk states
Jan
Feb
Mar
Apr
May
Jun
SNID round conducted on 15 January 2012 using buffer stock of bOPV
SNID planned on 18 March 2012 with bOPV 8 8

9. bOPV – supply status Nov 2010 to Mar 2012 Apr 2012 to Jun 2012
Total vaccine procured : mn
Total vaccine required :340 mn

10. bOPV procurement for SNIDs – Quarter 2, 2012 Summary
340 million doses of bOPV required
RITES has offered only 238 million doses
Of these, order placed for million doses
However only mn doses available during May and June, balance available between August & October 2012
Domestic procurement to meet shortfall

11. Key Issues Non- availability of required quantity of polio vaccine
Committed supplies not available as per scheduled timeline
Buffer stock used frequently to manage the gap in supply for conducting SNID/NID resulting in very low buffer stock and supply schedule not adequate to build up buffer
Last minute intimation of inability to supply committed vaccine by manufacturers
Limited manufacturers of tOPV and even lesser for bOPV
bOPV vaccine for May and June SNID not fully secured

12. Thanks